Guangzhou Baiyunshan (Germany) Performance
| GU5 Stock | EUR 2.12 0.02 0.95% |
On a scale of 0 to 100, Guangzhou Baiyunshan holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of -0.41, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Guangzhou Baiyunshan are expected to decrease at a much lower rate. During the bear market, Guangzhou Baiyunshan is likely to outperform the market. Please check Guangzhou Baiyunshan's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Guangzhou Baiyunshan's current trending patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Guangzhou Baiyunshan Pharmaceutical are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Guangzhou Baiyunshan reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 17.8 B | |
| Total Cashflows From Investing Activities | -931.6 M |
Guangzhou |
Guangzhou Baiyunshan Relative Risk vs. Return Landscape
If you would invest 153.00 in Guangzhou Baiyunshan Pharmaceutical on September 13, 2024 and sell it today you would earn a total of 59.00 from holding Guangzhou Baiyunshan Pharmaceutical or generate 38.56% return on investment over 90 days. Guangzhou Baiyunshan Pharmaceutical is currently producing 0.5665% returns and takes up 3.4537% volatility of returns over 90 trading days. Put another way, 30% of traded stocks are less volatile than Guangzhou, and 89% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Guangzhou Baiyunshan Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guangzhou Baiyunshan's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Guangzhou Baiyunshan Pharmaceutical, and traders can use it to determine the average amount a Guangzhou Baiyunshan's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.164
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GU5 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.45 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.57 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Guangzhou Baiyunshan is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Guangzhou Baiyunshan by adding it to a well-diversified portfolio.
Guangzhou Baiyunshan Fundamentals Growth
Guangzhou Stock prices reflect investors' perceptions of the future prospects and financial health of Guangzhou Baiyunshan, and Guangzhou Baiyunshan fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Guangzhou Stock performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0356 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 5.35 B | |||
| Shares Outstanding | 219.9 M | |||
| Price To Earning | 8.09 X | |||
| Price To Book | 1.07 X | |||
| Price To Sales | 0.1 X | |||
| Revenue | 69.01 B | |||
| EBITDA | 5.46 B | |||
| Cash And Equivalents | 21.69 B | |||
| Cash Per Share | 13.34 X | |||
| Total Debt | 752.81 M | |||
| Debt To Equity | 0.36 % | |||
| Book Value Per Share | 19.33 X | |||
| Cash Flow From Operations | 5.67 B | |||
| Earnings Per Share | 0.33 X | |||
| Total Asset | 66.12 B | |||
About Guangzhou Baiyunshan Performance
By analyzing Guangzhou Baiyunshan's fundamental ratios, stakeholders can gain valuable insights into Guangzhou Baiyunshan's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Guangzhou Baiyunshan has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Guangzhou Baiyunshan has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the Peoples Republic of China and internationally. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. GUANG BAIY operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 25168 people.Things to note about Guangzhou Baiyunshan performance evaluation
Checking the ongoing alerts about Guangzhou Baiyunshan for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Guangzhou Baiyunshan help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Guangzhou Baiyunshan appears to be risky and price may revert if volatility continues |
- Analyzing Guangzhou Baiyunshan's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Guangzhou Baiyunshan's stock is overvalued or undervalued compared to its peers.
- Examining Guangzhou Baiyunshan's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Guangzhou Baiyunshan's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Guangzhou Baiyunshan's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Guangzhou Baiyunshan's stock. These opinions can provide insight into Guangzhou Baiyunshan's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Guangzhou Stock analysis
When running Guangzhou Baiyunshan's price analysis, check to measure Guangzhou Baiyunshan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangzhou Baiyunshan is operating at the current time. Most of Guangzhou Baiyunshan's value examination focuses on studying past and present price action to predict the probability of Guangzhou Baiyunshan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangzhou Baiyunshan's price. Additionally, you may evaluate how the addition of Guangzhou Baiyunshan to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |